This is default featured post 1 title

This is our production in action 1 Photos

More details about our manufacturing capabilities, you can ohnakomistya on our site. »

This is default featured post 2 title

This is our production in action 2 Photos

More details about our manufacturing capabilities, you can ohnakomistya on our site. »

This is default featured post 3 title

This is our production in action 3 Photos

More details about our manufacturing capabilities, you can ohnakomistya on our site. »

This is default featured post 4 title

This is our production in action 4 Photos

More details about our manufacturing capabilities, you can ohnakomistya on our site. »

This is default featured post 5 title

This is our production in action 5 Photos

More details about our manufacturing capabilities, you can ohnakomistya on our site. »

The 2015 edition of Chinese Pharmacopoeia to enhance the overall level of China’s drug quality

The 2015 edition of Chinese Pharmacopoeia was recently adopted at the plenary session of the Executive Committee of the Tenth Chinese Pharmacopoeia Commission. On June 5, 2015, China Food and Drug Administration (CFDA) promulgated the 2015 edition of Chinese Pharmacopoeia, which will go into effect on December 1, 2015. The promulgation of the new edition of Chinese Pharmacopoeia marks the promotion of the level of China’s drug use, production and supervision. It will drive the overall improvement of drug quality and play a significant role in ensuring drug safety and effectiveness for the public.

CFDA issues Measures for Unannounced Inspection of Drugs and Medical Devices

China Food and Drug Administration (CFDA) recently issued the Measures for Unannounced Inspection of Drugs and Medical Devices, which will be implemented as of September 1, 2015. The Measures comprises 35 articles in five chapters, including the general provisions, initiating, inspection, handling and supplementary provisions.